Development and Commercialization of a Safe and Effective Mpox Subunit Vaccine with Global Impact

具有全球影响力的安全有效的 Mpox 亚单位疫苗的开发和商业化

• 批准号: 494292
• 负责人: Foster Leonard J
• 金额: $ 7.29万
• 依托单位: University of British Columbia
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2023
• 资助国家: 加拿大
• 起止时间: 2023-09-01 至 2024-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=494292&lang=en
• 关键词: Algorithm; Hla; Infection Models; Mhc; Mpox; Self-Amplifying Rna; Vaccine

In a rapidly changing global landscape characterized by expanding human populations, diminishing habitats, and evolving disease patterns influenced by climate change, the likelihood of zoonotic diseases transitioning to humans has escalated. The recent CO

在迅速变化的全球格局中，人口不断增加，栖息地不断减少，受气候变化影响的疾病模式不断演变，人畜共患病向人类转移的可能性已经升级。最近CO